---
title: 'EGeRepDR: An enhanced genetic based representation learning for drug repurposing
  using multiple biomedical sources'
date: '2023-10-20'
linkTitle: https://pubmed.ncbi.nlm.nih.gov/37858852/?utm_source=curl&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1x5bM_TNL8gjogAcnslpo2s2PbDe-61JVM2h9yowOYSiZ7Dkrt&fc=20220919211934&ff=20231020180535&v=2.17.9.post6+86293ac
source: (graph neural network) AND (gene)
description: 'MOTIVATION: Drug repurposing (DR) is an imminent approach to identifying
  novel therapeutic indications for the available drugs and discovering novel drugs
  for previously untreatable diseases. Nowadays, DR has major attention in the pharmaceutical
  industry due to the high cost and time of launching new drugs to the market through
  traditional drug development. DR task majorly depends on genetic information since
  the drugs revert the modified Gene Expression (GE) of diseases to normal. Many of
  ...'
disable_comments: true
---
MOTIVATION: Drug repurposing (DR) is an imminent approach to identifying novel therapeutic indications for the available drugs and discovering novel drugs for previously untreatable diseases. Nowadays, DR has major attention in the pharmaceutical industry due to the high cost and time of launching new drugs to the market through traditional drug development. DR task majorly depends on genetic information since the drugs revert the modified Gene Expression (GE) of diseases to normal. Many of ...